跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPC-3
首页
药物
SPC-3
SPC-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of sphingosylphosphorylcholine antagonist for restoring the expression of antimicrobial peptides
CN 101443347 A
申请人: AMOREPACIFIC CORP
优先权: 2006
CN
Separating identification of new compound furostanol saponin in smilacina japonica and antitumor application thereof
CN 101962398 B
申请人: UNIV JILIN AGRICULTURAL
优先权: 2009
CN
Application of conyza blinii total saponins for preparing anti-neoplastic drug
CN 101933964 A
申请人: UNIV TIANJIN
优先权: 2010
CN
Patch with cover member and patch kit with cover member
CN 105813636 A
申请人: HISAMITSU SEIYAKU K K
优先权: 2013
CN
Rupturable PEG modified adriamycin liposome preparation method
CN 105310983 A
申请人: SUN REN
优先权: 2014
CN
Consumable products comprising maltified cereals for promoting recovery of physical activity
CN 115605214 A
申请人: LANTMU NNEN HEALTH CARE AB SESE
优先权: 2020
CN
Preparation method of ergosterol combined afatinib liposome
CN 112618491 A
申请人: HANGZHOU RED CROSS HOSPITAL
优先权: 2020
CN
白木香花提取物及其药物与其制备方法和其应用
CN 113262258 B
申请人: 中国科学院昆明植物研究所
优先权: 2021
CN
ROS responsive bionic nano drug delivery system, preparation method and application
CN 119097716 A
申请人: UNIV MACAU SCI & TECH
优先权: 2023
CN
Novel long-acting preparation and preparation method thereof
CN 120643700 A
申请人: NANJING NINGDAN NEW DRUG TECH CO LTD
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈